BIM
BIO icon

BlackRock Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

BlackRock Investment Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$13.3M Buy
72,986
+11,870
+19% +$2.02M 0.02% 924
2016
Q3 		$10M Sell
61,116
-294
-0.5% -$44.6K 0.01% 1009
2016
Q2 		$8.78M Sell
61,410
-4,519
-7% -$645K 0.01% 1043
2016
Q1 		$9.01M Buy
65,929
+213
+0.3% +$28K 0.01% 988
2015
Q4 		$9.11M Buy
65,716
+263
+0.4% +$36.5K 0.01% 997
2015
Q3 		$8.79M Buy
65,453
+3,293
+5% +$474K 0.01% 1001
2015
Q2 		$9.36M Buy
62,160
+3,842
+7% +$550K 0.01% 1042
2015
Q1 		$7.88M Buy
58,318
+305
+0.5% +$37.8K 0.01% 1090
2014
Q4 		$6.99M Sell
58,013
-320
-0.5% -$36.8K 0.01% 1162
2014
Q3 		$6.62M Buy
58,333
+1,043
+2% +$124K 0.01% 1163
2014
Q2 		$6.86M Sell
57,290
-642
-1% -$78.4K 0.01% 1194
2014
Q1 		$7.42M Sell
57,932
-668
-1% -$85.6K 0.01% 1102
2013
Q4 		$7.24M Sell
58,600
-182
-0.3% -$22.2K 0.01% 1105
2013
Q3 		$6.91M Buy
58,782
+4,425
+8% +$522K 0.01% 1089
2013
Q2 		$6.1M Buy
+54,357
New +$6.38M 0.01% 1079

Other funds holding BIO

ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

BlackRock Investment Management's BIO Position: Q4 2016 in Review

BlackRock Investment Management increased its Bio-Rad Laboratories Class A (BIO) stake by 19% in Q4 2016, buying an estimated $2.02M and bringing the position to 72,986 shares worth $13.3M. The position accounts for 0.02% of the portfolio, ranked #924.

BlackRock Investment Management first reported a position in BIO in Q2 2013 and has held it in 15 quarters since. 261 funds tracked by Wall St. Rank hold BIO as of Q4 2016.

  • BlackRock Investment Management held 72,986 shares of Bio-Rad Laboratories Class A worth $13.3M as of Q4 2016.
  • BlackRock Investment Management bought 11,870 Bio-Rad Laboratories Class A shares in Q4 2016, an estimated $2.02M.
  • Bio-Rad Laboratories Class A made up 0.02% of BlackRock Investment Management's portfolio in Q4 2016, its #924 holding.
  • BlackRock Investment Management first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 15 quarters since.
  • 261 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.